Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $28.4 million.

  • Generation Bio's Non-Current Assets fell 5057.54% to $28.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.9 million, marking a year-over-year decrease of 4748.87%. This contributed to the annual value of $38.3 million for FY2024, which is 6250.83% down from last year.
  • According to the latest figures from Q3 2025, Generation Bio's Non-Current Assets is $28.4 million, which was down 5057.54% from $33.9 million recorded in Q2 2025.
  • Over the past 5 years, Generation Bio's Non-Current Assets peaked at $102.5 million during Q1 2022, and registered a low of $28.4 million during Q3 2025.
  • Over the past 5 years, Generation Bio's median Non-Current Assets value was $60.8 million (recorded in 2021), while the average stood at $68.9 million.
  • In the last 5 years, Generation Bio's Non-Current Assets skyrocketed by 7576.33% in 2022 and then plummeted by 6250.83% in 2024.
  • Over the past 5 years, Generation Bio's Non-Current Assets (Quarter) stood at $97.6 million in 2021, then dropped by 8.54% to $89.2 million in 2022, then grew by 14.45% to $102.1 million in 2023, then tumbled by 62.51% to $38.3 million in 2024, then decreased by 25.75% to $28.4 million in 2025.
  • Its Non-Current Assets stands at $28.4 million for Q3 2025, versus $33.9 million for Q2 2025 and $36.2 million for Q1 2025.